Abstract
Following the first descriptions of the dermatoscopic pattern of basal cell carcinoma (BCC) that go back to the very early years of dermatoscopy, the list of dermatoscopic criteria associated with BCC has been several times updated and renewed. Up to date, the usefulness of dermatoscopy in differentiating pigmented and non-pigmented BCC from other skin tumors has been extensively demonstrated. In addition to its well-documented value in improving the diagnosis, dermatoscopy continuously gains an essential role in the management of BCC.
Dermatoscopy for choosing the appropriate treatment modality
In our era, the therapeutic armamentarium of clinicians for BCC includes several surgical methods as well as non-surgical modalities. The choice of the appropriate treatment depends on several factors including the histopathologic subtype, the presence of pigmentation or ulceration, the tumor depth, the anatomical site and the presence of residual disease or recurrence. Dermatoscopy has been shown to provide valuable information for several of the aforementioned parameters.
The histopathologic subtype is the most crucial factor influencing the treatment choice for BCC. In the recent years, sBCC has been shown to respond perfectly to non-ablative treatments such as imiquimod or photodynamic therapy, prompting experts to recommend the latter modalities as first-line therapeutic options for this subtype. In contrast, conventional or Mohs surgery is considered the choice treatment for nodular, infiltrative and sclerodermiform subtypes, while non-surgical treatments are much less effective.
A recent study investigated the accuracy of dermatoscopic criteria for discriminating superficial from the other subtypes of BCC. This is particularly relevant in clinical practice, since the possible misinterpretation of a nodular or infiltrate tumor as superficial BCC could lead the clinician to the inappropriate choice of a non-surgical treatment modality. According to the results of the latter study, the presence of short fine telangiectasia, multiple small erosions and structures corresponding to dermo-epidermal pigmentation predict the superficial subtype. In contrast, detection of ovoid nests should lead clinicians to exclude the diagnosis of superficial BCC, while arborizing vessels and large ulcerations are also suggestive of nodular, sclerodermiform or infiltrative tumors.
The presence of pigmentation is not routinely reported in histopathologic reports, since in the past it was not considered to influence the management and prognosis of the tumor. However, the use of PDT in BCC treatment restored the importance of pigmentation, since its presence was shown to influence the tumor’s response. In detail, case series studies reported a poor response of pigmented BCC to PDT, compared to non-pigmented variants (14% versus 62–100%). The low efficacy of PDT in pigmented tumors has been attributed to melanin, which appears to act as a competitive light-absorbing pigment, decreasing response rates.
Effectively, the presence of clinically undetectable pigmentation might represent a diagnostic pitfall for clinicians, forcing them to apply an ineffective treatment on a subset of BCCs. This problem seems to be, at least partially, solved by the application of dermatoscopy, which was recently shown to reveal clinically undetectable pigmentation in approximately 30% of macroscopically non-pigmented BCCs, enhancing clinicians to better select tumors potentially sensitive to PDT and minimizing treatment failures.
Dermatoscopy for assessing excision margins
Dermatoscopy, by providing a more accurate assessment of the true extension of the tumor, allows a more precise estimation of the required surgical margins, helping to minimize the recurrence rate. The discrimination of BCC vessels from the dermal plexus vasculature of the surrounding healthy skin can be based on the blurred appearance and dark red-to-purple color of the surrounding sun-damaged skin, in contrast to the bright-red and focused vessels of the tumor. However, while the diagnostic significance of pigmented structures is unquestionable, the usefulness of vascular structures in defining the surgical margins is controversial. It has been suggested that arborizing vessels do not directly correspond to BCC cells, but represent feeding vessels of the tumor and may extend also to the perilesional skin. Subsequently, if the extension of vessels is used to define the excision margins, there is the risk of unnecessarily removing healthy skin surrounding the BCC. Although the latter hypothesis seems reasonable, it was supported by only one published case and, accordingly, the question whether vascular structures should be considered for defining surgical margins of BCC remains to be further elucidated.
Dermatoscopy for monitoring response to non-ablative treatments
A common problem associated with non-ablative modalities is the post-treatment evaluation, since at the end of a treatment cycle, the clinical morphology of the lesion often does not allow a reliable estimation of the possible presence of residual disease.
Dermatoscopy has the potential to improve the post-treatment evaluation of BCC following non-ablative procedures, minimizing therefore the risks of under- or over-treatment of BCC. Specifically, the disappearance of the dermatoscopic criteria of BCC after treatment has been shown to accurately predict histopathologic clearance, while the persistence of some BCC criteria correlates well with the presence of residual disease. According to the results of a recent study, the presence of arborizing vessels, ulceration or pigmented structures (e.g., blue-gray ovoid nests and maple leaf-like areas) accurately predicts residual disease, and should prompt the clinician to continue the treatment. Instead, red/white structureless areas and/or superficial fine telangiectasia might represent equivocal features, since they do not always correspond to residual disease. Effectively, detection of the latter criteria warrants close monitoring to recognize a possible recurrence of the BCC.